drugset / Trial / NCT00461916

Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin

NCT00461916

Phase 4 Completed 182 enrolled Tehran University of Medical Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether half-dose depot triptorelin are as effective as reduced-dose daily buserelin in the controlled ovarian stimulation for intracytoplasmic sperm injection and embryo transfer

Timeline

Start
2005-05
Primary completion
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Triptorelin Other / unclassified 1.87 mg Intramuscular
Subject buserelin Unknown 0.25 mg Subcutaneous

Indications